Campbell Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-22,235
Closed -$1.87M 52
2025
Q3
$1.87M Buy
+22,235
New +$1.83M 0.72% 27
2025
Q2
Sell
-100
Closed -$8.98K 68
2025
Q1
$8.98K Hold
100
0.01% 55
2024
Q4
$9.95K Buy
+100
New +$10.3K ﹤0.01% 78
2020
Q1
Sell
-52,154
Closed -$4.53M 50
2019
Q4
$4.53M Sell
52,154
-587
-1% -$48.2K 2.78% 15
2019
Q3
$4.24M Hold
52,741
3.15% 13
2019
Q2
$4.22M Sell
52,741
-23,904
-31% -$1.83M 3.37% 12
2019
Q1
$6.08M Sell
76,645
-210
-0.3% -$15.7K 4.4% 9
2018
Q4
$5.6M Buy
+76,855
New +$5.43M 7.14% 5

Other funds holding MRK

Campbell Capital Management's MRK Position: Q4 2025 in Review

Campbell Capital Management sold out of Merck (MRK) in Q4 2025, closing a stake of 22,235 shares — an estimated $1.87M sold.

Campbell Capital Management first reported a position in MRK in Q4 2018 and held it in 8 quarters. The position peaked at $6.08M in Q1 2019. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Campbell Capital Management reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Campbell Capital Management sold 22,235 Merck shares in Q4 2025, an estimated $1.87M.
  • Campbell Capital Management first reported a position in Merck in Q4 2018 and held it in 8 quarters.
  • Campbell Capital Management's Merck position peaked at $6.08M in Q1 2019.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Campbell Capital Management's 13F filing for Q4 2025, filed 28 Jan 2026.